A Prospective Trial of Enavogliflozin to Evaluate Cardio-renal Outcome in Type 2 Diabetes Mellitus Patients

Clinical trial NCT06642623 · RECRUITING

Trial details

NCT number: NCT06642623
Sponsor: Yonsei University
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 2 Cardiovascular Diseases Kidney Diseases

Start date: 2024-01-22
Primary completion: 2029-09-30
Enrollment: 2862

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.